<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comparison of pharmacokinetics for intravenous and subcutaneous immune globulin</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comparison of pharmacokinetics for intravenous and subcutaneous immune globulin</h1>
<div class="graphic"><div class="figure"><div class="ttl">Comparison of pharmacokinetics for intravenous and subcutaneous immune globulin</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Immune globulin pharmacokinetics for IVIG, SCIG, and fSCIG administration. The graph shows an illustration of the differences in the levels of IgG in the blood following IVIG (red dotted) and fSCIG infusion (blue solid), both given as a first infusion, compared with traditional SCIG (gray dashed), shown at a steady state over a 28-day time period. The differences in the pharmacokinetics of the three delivery modalities show the loss of the IVIG peak level with fSCIG, followed by a similar gradual decline in IgG levels over the dosing cycle. Traditional SCIG at steady state is characterized by very stable levels and a higher "trough" IgG level than IVIG or fSCIG. Levels of IgG on the Y-axis are given in g/L. Equivalent values in mg/dL are 0 to 2500 mg/dL.</div><div class="graphic_footnotes">IVIG: intravenous immune globulin; IgG: immunoglobulin G; fSCIG: facilitated subcutaneous immune globulin; SCIG: subcutaneous immune globulin.</div><div class="graphic_reference">Republished with permission of Dove Medical Press Ltd., from Jolles S, Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency, ImmunoTargets and Therapy 2013; Vol. 2: Pg. 125; permission conveyed through Copyright Clearance Center, Inc.</div><div id="graphicVersion">Graphic 104410 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
